Reimbursement Potential of Collaborative Care Model (CoCM) Billing Codes for Opioid Use Disorder Co-Occurring with Mental Disorders

Why It Matters

The gap between billable and non‑billable CoCM activities threatens the financial sustainability of integrated opioid‑treatment programs, influencing provider adoption and payer policy.

Key Takeaways

• 56% of care‑manager minutes qualify for CoCM billing
• Ideal reimbursement equals $91.61 per care‑management hour
• Restrictive billing reduces rate to $79.32 per hour
• Medicaid scenarios drop reimbursement to $39‑43 per hour
• Unbillable minutes often exceed monthly maximum or miss service criteria

Pulse Analysis

The Collaborative Care Model has become a cornerstone for embedding behavioral health within primary care, offering a structured team‑based approach that improves outcomes for patients with mental health and substance‑use disorders. Since Medicare’s 2017 approval of specific CoCM billing codes, providers have been able to capture some of the costs associated with care‑manager time, psychiatric consultation, and systematic follow‑up. However, the model’s financial viability hinges on how well real‑world service delivery aligns with the strict criteria embedded in those codes, especially when treating high‑needs groups such as individuals battling opioid dependence alongside depression or PTSD.

The RAND trial provides a granular look at that alignment. By tracking nearly 91,000 minutes of care‑manager activity, researchers found that just over half of the time could be billed under current Medicare rules, translating to $91.61 per hour under ideal conditions. When payers impose tighter restrictions—common in many state Medicaid programs—the effective rate drops to $79.32, and in the most conservative Medicaid scenarios it can fall below $45 per hour. The primary drivers of unbillable time were activities that exceeded monthly caps or failed to meet the defined service components, underscoring a structural mismatch between clinical practice and reimbursement policy.

For health systems and policymakers, these findings signal a need to recalibrate billing frameworks to reflect the intensity of care required for co‑occurring opioid and mental‑health disorders. Adjustments could include expanding allowable minutes, redefining service thresholds, or creating supplemental codes for high‑complexity cases. Aligning reimbursement with clinical reality would not only improve the financial sustainability of CoCM programs but also expand access to evidence‑based treatment for a vulnerable population, ultimately reducing the broader societal costs of the opioid crisis.